1 asset in Peroxisome Biogenesis Disorder

Therapeutic assets addressing Peroxisome Biogenesis Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cald Hr-D Peroxisome Biogenesis Disorder	Masonic Cancer Center, University of Minnesota	P2	CCC (53)